register

News & Trends - Pharmaceuticals

Clinically superior and fast-acting vitamin D launches in Australia

Health Industry Hub | March 3, 2021 |

To address global concerns and needs in supporting immune health, Royal DSM, a global science-based company, launched ampli-D, a fast-acting and highly potent form of Vitamin D for dietary supplements in Australia.

ampli-D is a faster and more effective way for Australians to boost Vitamin D levels in the body in just days and weeks instead of months to support immune health.

The availability of DSM’s ampli-D in Australia, the first market for its launch, follows regulatory approval by Australia’s Therapeutic Goods Administration (TGA) for its use in dietary supplements that do not require a prescription.

Despite its importance to health and well-being, Vitamin D deficiency is a prevalent global health issue and more than 80% of the world’s population have sub-optimal levels of Vitamin D in their body. Even in sunny Australia, the Australian Bureau of Statistics (ABS) calculated that one in five Australian adults are deficient in Vitamin D and an additional 43% have sub-optimal levels.

Interview links will be provided via email next week.

“Vitamin D is typically obtained through sunlight, diet and supplements but many people don’t realise that they don’t get enough and quickly enough. With today’s concerns on health and well-being, Vitamin D is an important micronutrient that helps to enhance immune system function, and emerging scientific evidence supports the important role of Vitamin D in the body’s response in resolving and lowering the risk of acute respiratory tract infections,” said Dr Michela Sorensen, Australian GP.

Getting to sufficient levels of vitamin D in the body can be challenging due to limited food sources and a person’s direct exposure to sunlight which is affected by the seasons throughout the year, skin colour, and use of protective clothing and sun protection. Even with an intake of traditional Vitamin D supplements like D3 or fortified food, it can still take several months to achieve healthy Vitamin D levels in the bloodstream.

Peter Van Dael, SVP Nutrition Science at DSM, explains “In the human body, Vitamin D needs to be first processed by the liver and converted into Calcifediol to be processed further in the kidneys. The whole process is slow and it can easily take several months to achieve healthy levels in the bloodstream. With ampli-D, Calcifediol or 25-Hydroxyvitamin D3, the common form of Vitamin D in the body is now also available as a dietary supplement. Research and clinical studies have shown that ampli-D works three times faster and more effectively than conventional Vitamin D3 supplements, helping the body get to optimal Vitamin D levels in days and weeks instead of months.”

Recent events have also put a spotlight on the importance of a strong and healthy immune system. In a recent consumer study conducted by DSM in 2020 with 12,000 participants across 24 countries, 65% of the global participants ranked immunity as one of their top 3 health concerns.

Carmel Power, Head of Human Nutrition, Oceania at DSM said, “Supporting our immune health is important throughout our lives and it is more important than ever to do it more effectively with the emergence of new threats to human health. DSM is committed to addressing global health concerns such as immunity and keeping the growing global population healthy. The introduction of ampli-D in Australia shows how we want to champion this purpose – by accelerating the availability of our industry-leading nutritional solutions through market-ready solutions for our partners and consumers.”

Leading DSM customer, Factors Group has recently launched Opti Active D containing ampli-D, under their practitioner-only range of evidence based dietary supplements, Bioclinic Naturals.

In addition, DSM has also launched its own dietary supplement product with ampli-D in tablet form for Australian consumers, branded as FORTARO. It Is available for purchase on fortaro.com


News & Trends - Biotechnology

AusBiotech appoints new CEO: Former Sanofi corporate affairs and sustainability leader takes the helm

AusBiotech appoints new CEO: Former Sanofi corporate affairs and sustainability leader takes the helm

Health Industry Hub | April 23, 2024 |

Biotech News: AusBiotech, the nation’s leading industry body for the biotech sector, has named former leader at Sanofi, Rebekah Cassidy, […]

More


News & Trends - MedTech & Diagnostics

Federal government invests in Siemens Healthineers scanner to 'reduce wait times' for cancer diagnosis

Federal government invests in Siemens Healthineers scanner to ‘reduce wait times’ for cancer diagnosis

Health Industry Hub | April 23, 2024 |

MedTech & Diagnostics News: The Albanese Government is investing $12 million through the 2024–25 Budget, to purchase and install a […]

More


News & Trends - MedTech & Diagnostics

Cardiac device benefits face more cuts, while technical services remain secure in the short term

Cardiac device benefits face more cuts, while technical services remain secure in the short term

Health Industry Hub | April 23, 2024 |

MedTech & Diagnostics News: Starting from July 2024, Cardiac Implantable Electronic Devices (CIED) listed on the Prescribed List (PL) will […]

More


News & Trends - Biotechnology

CSL's world-first gene therapy heads for MSAC assessment

CSL’s world-first gene therapy heads for MSAC evaluation

Health Industry Hub | April 23, 2024 |

Biotech News: CSL’s world-first gene therapy for haemophilia B is scheduled for consideration at the upcoming Medical Services Advisory Committee (MSAC) […]

More


This content is copyright protected. Please subscribe to gain access.